0001231919-21-000019.txt : 20210218 0001231919-21-000019.hdr.sgml : 20210218 20210218143352 ACCESSION NUMBER: 0001231919-21-000019 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 EFFECTIVENESS DATE: 20210218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEMOSHEAR THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001846099 IRS NUMBER: 861288232 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-389840 FILM NUMBER: 21649058 BUSINESS ADDRESS: STREET 1: 501 LOCUST AVENUE, SUITE 301 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 434 872-0196 MAIL ADDRESS: STREET 1: 501 LOCUST AVENUE, SUITE 301 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 D 1 primary_doc.xml X0708 D LIVE 0001846099 HEMOSHEAR THERAPEUTICS, INC. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 434 872-0196 DELAWARE None None Corporation true 2020 James C. Powers c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Executive Officer Director Aric R. Holsinger c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Executive Officer John L. Brooks c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Director Robert J. Gould c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Director Kathleen M. Metters c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Director W. M. Thompson, Jr. c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Executive Officer H. Thomas Watkins III c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Director Brian Wamhoff c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Executive Officer Brian A. Johns c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Executive Officer John Tilton c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Director David Friedman c/o HemoShear Therapeutics, Inc. 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22902 Director Other Health Care Decline to Disclose 06b false 2021-02-05 false true true Offer and sale of Series A Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof. false 0 48102069 43102017 5000052 Total amount sold includes the value of cancelled indebtedness formerly held by certain purchasers in the aggregate principal and interest amount of approximately $3,102,069.37. false 17 0 0 0 false HEMOSHEAR THERAPEUTICS, INC. /s/Aric Holsinger Aric Holsinger Chief Financial Officer 2021-02-18